The authors present two cases of pregnant women with coagulation disorders--one with inherited deficiency of factor VII and the second with chronic hepatitis. Both cases were successfully treated with recombinant activated factor VII of coagulation (NovoSeven) in delivery. The advantages of using this product are discussed.
Department of Obstetrics and Gynecology, Medical University, 15-a Vassil Aprilov Str, Plovdiv 4000, Bulgaria. blago1956@yahoo.com
Eur. J. Obstet. Gynecol. Reprod. Biol. 2004 Oct 15;116(2):237-8.
AbstractThe authors present two cases of pregnant women with coagulation disorders--one with inherited deficiency of factor VII and the second with chronic hepatitis. Both cases were successfully treated with recombinant activated factor VII of coagulation (NovoSeven) in delivery. The advantages of using this product are discussed.